Armata Pharmaceuticals, Inc. - 8-K Filing
Armata Pharmaceuticals promoted David House as Chief Financial Officer effective July 17, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $ARMP